BIO
Price
$295.34
Change
+$5.91 (+2.04%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
7.8B
47 days until earnings call
CYDX
Price
$0.25
Change
-$0.00 (-0.00%)
Updated
Aug 26 closing price
Capitalization
1.32M
Interact to see
Advertisement

BIO vs CYDX

Header iconBIO vs CYDX Comparison
Open Charts BIO vs CYDXBanner chart's image
Bio-Rad Laboratories
Price$295.34
Change+$5.91 (+2.04%)
Volume$400
Capitalization7.8B
CYduct Diagnostics
Price$0.25
Change-$0.00 (-0.00%)
Volume$1.13K
Capitalization1.32M
BIO vs CYDX Comparison Chart in %
Loading...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIO vs. CYDX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a Hold and CYDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BIO: $295.43 vs. CYDX: $0.25)
Brand notoriety: BIO and CYDX are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BIO: 95% vs. CYDX: 379%
Market capitalization -- BIO: $7.8B vs. CYDX: $1.32M
BIO [@Medical/Nursing Services] is valued at $7.8B. CYDX’s [@Medical/Nursing Services] market capitalization is $1.32M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 0 FA rating(s) are green whileCYDX’s FA Score has 1 green FA rating(s).

  • BIO’s FA Score: 0 green, 5 red.
  • CYDX’s FA Score: 1 green, 4 red.
According to our system of comparison, BIO is a better buy in the long-term than CYDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 4 TA indicator(s) are bullish while CYDX’s TA Score has 2 bullish TA indicator(s).

  • BIO’s TA Score: 4 bullish, 4 bearish.
  • CYDX’s TA Score: 2 bullish, 0 bearish.
According to our system of comparison, CYDX is a better buy in the short-term than BIO.

Price Growth

BIO (@Medical/Nursing Services) experienced а -0.82% price change this week, while CYDX (@Medical/Nursing Services) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.04%. For the same industry, the average monthly price growth was +4.21%, and the average quarterly price growth was +24.44%.

Reported Earning Dates

BIO is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.04% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIO($7.8B) has a higher market cap than CYDX($1.32M). CYDX YTD gains are higher at: 65.746 vs. BIO (-10.070).
BIOCYDXBIO / CYDX
Capitalization7.8B1.32M590,765%
EBITDA656MN/A-
Gain YTD-10.07065.746-15%
P/E Ratio26.64N/A-
Revenue2.55BN/A-
Total Cash1.37BN/A-
Total Debt1.41BN/A-
FUNDAMENTALS RATINGS
BIO vs CYDX: Fundamental Ratings
BIO
CYDX
OUTLOOK RATING
1..100
6537
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
86100
PRICE GROWTH RATING
1..100
4855
P/E GROWTH RATING
1..100
48100
SEASONALITY SCORE
1..100
950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYDX's Valuation (33) in the null industry is somewhat better than the same rating for BIO (81) in the Medical Specialties industry. This means that CYDX’s stock grew somewhat faster than BIO’s over the last 12 months.

CYDX's Profit vs Risk Rating (100) in the null industry is in the same range as BIO (100) in the Medical Specialties industry. This means that CYDX’s stock grew similarly to BIO’s over the last 12 months.

BIO's SMR Rating (86) in the Medical Specialties industry is in the same range as CYDX (100) in the null industry. This means that BIO’s stock grew similarly to CYDX’s over the last 12 months.

BIO's Price Growth Rating (48) in the Medical Specialties industry is in the same range as CYDX (55) in the null industry. This means that BIO’s stock grew similarly to CYDX’s over the last 12 months.

BIO's P/E Growth Rating (48) in the Medical Specialties industry is somewhat better than the same rating for CYDX (100) in the null industry. This means that BIO’s stock grew somewhat faster than CYDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOCYDX
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
63%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
43%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
45%
Advances
ODDS (%)
Bullish Trend 8 days ago
70%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
66%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IIGCX16.430.42
+2.62%
VanEck International Investors Gold C
AMEFX27.20N/A
N/A
American Funds Income Fund of Amer F2
CGTUX108.82N/A
N/A
Columbia Global Technology Growth Inst3
IENSX32.16N/A
N/A
Invesco Energy R6
PZINX12.49N/A
N/A
Pzena International Value Instl

CYDX and

Correlation & Price change

A.I.dvisor tells us that CYDX and INMD have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYDX and INMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYDX
1D Price
Change %
CYDX100%
N/A
INMD - CYDX
23%
Poorly correlated
-0.69%
BIO - CYDX
20%
Poorly correlated
+0.48%
SOAGY - CYDX
15%
Poorly correlated
-3.52%
MASS - CYDX
8%
Poorly correlated
-0.36%
LUDG - CYDX
4%
Poorly correlated
+29.48%
More